Noordelijke Refereeravond Radiotherapie
The department of Radiation Oncology is very pleased to invite you to the upcoming research meeting Noordelijke Refereeravond Radiotherapie
Radiotherapy and systemic treatment are both cornerstones in the treatment of Hodgkin Lymphoma, resulting in high cure rates. Despite the developments over the last decades, late treatment-related complications, especially cardiac toxicity and secondary malignancies, are remaining side effects.
Insight in the factors contributing to the development of these side effects is crucial to develop primary and secondary preventive strategies. Primary prevention in radiotherapy mainly focuses on reducing the radiation dose to organs at risk by new radiation technologies. Despite the introduction of new photon-based technologies, radiation dose to normal tissues still is substantial.
At present, the national indication protocol for proton therapy is under development. During this research meeting, a number of experts in the field will discuss the limitations of current treatment of Hodgkin lymphoma and the potential advantages and challenges related to the introduction of proton therapy.
Radiation oncologists, hematologists, residents, medical physicists and RTT’s.
|17.30 - 17.55|
Welcome and registration. Sandwiches will be served at 17:30
17:55 - 18:00
Max Beijert, MD, PhD, Radiation Oncologist, UMCG
18:00 - 18:30
Cardiovascular toxicity after radiotherapy of Hodgkin Lymphoma patients
Berthe Aleman, MD PhD, Radiation Oncologist, NKI-AVL
18:30 - 19:00
Latest insights in the systemic treatment of Hodgkin lymphoma, how to be just as good with less toxicity?
Wouter Plattel, MD, Hematologist, UMCG
19:00 - 19:20
19:20 - 19:50
Challenges in the mediastinal lymphoma proton pencil beam scanning treatment, planning and delivery
Prof. Stefan Both, PhD, DABR, FAAPM, Head of Medical Physics, department of Radiation Oncology, UMCG
19:50 - 20:10
Paneldiscussie en dialoog onder leiding van Marian Verkerk
The near future, steps to be taken to treat patients with proton therapy
Anne Niezink, MD, Radiation Oncologist, UMCG
Registration and further information
Please be aware that registration in advance is mandatory. Registration will be on the ‘first come, first serve’ basis. We kindly request you to registrate at: .
Secretariat Radiation Oncology UMCG, telephone numer +31(0)50 361 55 32.